BPC-157 Dosage: Complete Protocol Guide (Oral vs Injection) — BPC-157
    Articles/BPC-157 Dosage Protocol
    BPC-157
    Dosage Guide

    BPC-157 Dosage: Complete Protocol Guide (Oral vs Injection)

    BPC-157 is one of the most widely researched recovery peptides available, with an extensive body of animal studies supporting its effects on tendon, muscle, gut, and nerve healing. This guide covers the two main administration routes — subcutaneous injection and oral — the dose ranges used in research, cycle structures, and how to choose the right approach for your specific application.

    Research use only. BPC-157 has no FDA approval for human therapeutic use. All dosing information below is derived from animal studies and practitioner reports — not human clinical trials. Consult a medical professional before any self-administration decision.

    Oral vs Injection: Which Route to Choose

    The route you choose should be determined by your target application. BPC-157 is unusual among research peptides in that oral administration has genuine, documented utility — but only for gut-related applications. For any systemic or musculoskeletal application, injection is required.

    AspectOralInjection (SubQ)
    BioavailabilityPartial — peptide partially survives gastric acidNear-complete — bypasses digestive breakdown
    Best applicationGut mucosal repair, IBD, leaky gut, ulcersTendon, muscle, ligament, bone, systemic, nerve
    Dose required1,000–2,000 mcg/day200–500 mcg/injection
    Ease of useSimpler — dissolve in water and drinkRequires sterile technique and reconstitution
    Pain/discomfortNoneMinimal with insulin syringe
    OnsetSlower for gut effects (days to weeks)May be faster for systemic tissue effects

    Dosage Protocols

    The following protocols are based on doses used in animal model research, scaled to human weight equivalents, and informed by practitioner reports from the research community.

    Injury Recovery (SubQ Injection)

    Dose

    200–500 mcg per injection

    Frequency

    Once or twice daily

    Cycle length

    4–12 weeks depending on injury severity

    Timing

    No strong timing requirement; some researchers dose morning and evening

    Inject near the injury site when possible. Use the lower end of the range for minor injuries; higher end for chronic or severe tissue damage.

    Gut Health / IBD (Oral)

    Dose

    1,000–2,000 mcg per day (1–2 mg)

    Frequency

    Once daily, split into two doses if desired

    Cycle length

    4–8 weeks

    Timing

    On an empty stomach for gut mucosal contact

    Oral BPC-157 is primarily for gastrointestinal applications — it does not survive digestion well enough to produce systemic effects. For gut repair, this is the correct route; for tendon/muscle/systemic effects, injection is required.

    Systemic Maintenance (SubQ)

    Dose

    200–250 mcg per injection

    Frequency

    Once daily

    Cycle length

    8 weeks on, 4 weeks off

    Timing

    Morning or pre-workout

    Lower dose for ongoing maintenance and general tissue resilience rather than acute injury. A common approach for researchers who have completed a loading phase.

    Loading vs Maintenance Phase

    Some researchers use a two-phase approach, though this is based on practitioner convention rather than formal study design:

    Loading Phase (Weeks 1–4)

    Higher dose twice daily (400–500 mcg per injection) to establish tissue saturation during the most active healing window. Used when addressing an acute injury.

    Maintenance Phase (Weeks 5–12)

    Drop to 200–250 mcg once daily. Continue to support ongoing tissue remodelling without maintaining unnecessarily high plasma levels.

    Off Cycle (4+ weeks)

    Most researchers cycle off after 8–12 weeks. There is no published evidence of receptor downregulation or tolerance, but cycling is the standard conservative practice in the research community.

    What You Need for Injection Dosing
    • BPC-157 lyophilised powder (typically 5mg vials) — source from a verified supplier with CoA
    • Bacteriostatic water for reconstitution — not plain sterile water
    • U-100 insulin syringes (1ml, 0.5" or 5/16" needle)
    • Alcohol swabs for vial tops and injection site
    • The Peptide Basics dosage calculator for accurate unit conversions

    All dosage ranges listed are for research purposes only. No dose has been validated in large-scale human trials. Individual responses vary. Do not use this guide as a substitute for medical advice.